Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease. Nishioka K, Ogino H, Chinen T, Ihara E, et al. J Gastroenterol 2021 Aug 27. pii: 10.1007/s00535-021-01819.

Read + Share

Amedeo Smart

Independent Medical Education

Nishioka K, Ogino H, Chinen T, Ihara E, et al. Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease. J Gastroenterol 2021 Aug 27. pii: 10.1007/s00535-021-01819.
PMID: 34448069